Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Integra LifeSciences Holdings Corporation (IART) had Cost of Goods Sold of $728.47M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$1.61B
Net Income	$-6.94M
Cost of Goods Sold	$728.47M
Gross Profit	$882.06M
Operating Expenses	$1.58B
Operating Income	$28.41M
Non-Operating Income/Expense	$-46.65M
Pre-Tax Income	$-18.24M
Normalized Pre-Tax Income	$-18.24M
Income after Taxes	$-6.94M
Income from Continuous Operations	$-6.94M
Consolidated Net Income/Loss	$-6.94M
Normalized Income after Taxes	$-6.94M
EBIT	$28.41M
EBITDA	$174.90M
Weighted-Average Shares Outstanding (Basic)	77.01M
Weighted-Average Shares Outstanding (Diluted)	77.01M
Earnings per Share (EPS) (Basic)	$-0.09
Earnings per Share (EPS) (Diluted)	$-0.09
Balance Sheet Financials
Current Assets	$1.08B
Property, Plant, and Equipment	$405.72M
Long-Term Assets	$2.96B
Total Assets	$4.04B
Current Liabilities	$922.13M
Long-Term Debt	$1.20B
Long-Term Liabilities	$1.57B
Total Liabilities	$2.49B
Common Equity	$1.55B
Tangible Shareholders Equity	$-759.26M
Shareholders Equity	$1.55B
Common Shares Outstanding	81.72M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$129.38M
Cash Flow from Investing Activities	$-390.81M
Cash Flow from Financial Activities	$237.86M
Beginning Cash	$276.40M
End Cash	$246.38M
Increase/Decrease in Cash	$-30.03M
Stock-Based Compensation	$24.38M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.17
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.44
Debt to Equity Ratio	1.17
Gross Margin	54.77%
Operating Margin	1.76%
EBIT Margin	1.76%
EBITDA Margin	10.86%
Pre-Tax Profit Margin	-1.13%
Profit Margin	-0.43%
Free Cash Flow	$24.96M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.40
Inventory Turnover	1.70
Receiveable Turnover	5.91
Days Sales in Receivables	61.73
Return on Equity	-0.45%
Return on Tangible Equity	0.91%
Return on Assets	-0.17%
Return on Investments	-0.25%
Book Value Per Share	$18.91
Free Cash Flow per Share	$0.32
Operating Cash Flow per Share	$1.68

Data from Zacks Investment Research, Inc.